Friedman LLP's Life Sciences Service Group works with pharmaceutical, specialty pharmaceutical, biotechnology, medical device companies, and other related businesses, at every stage of their lifecycles.
Selecting the right service provider is an extremely important decision. Rest assured, we understand the high price paid to be a successful life science company: costly R&D cycles, complex clinical trials, lengthy government agency reviews, product launch complexities, challenging financing and capital raises as well as complex collaborative agreements just to name a few. That's why it is crucial to partner with a firm that enables private and public life sciences companies and their bio-entrepreneurs to be innovative and work creatively, while providing complete comfort that the accounting, reporting and tax compliance associated with innovative capital, financing, licensing and other collaborative arrangements are properly managed and assessed.
Just as your company benefits and values its intellectual property and intangibles, you will benefit from Friedman's intangibles - personal attention, prompt and accurate responses to questions, frequent and ongoing communication, quick resolution to issues and collaborative and proactive interaction with management - the simple yet differentiating attributes among firms.
Proud Member of:
Stock News Now featured an exclusive article from Robert E. Fiorentino, CPA, Partner showcasing must-know financial disclosure insights for BioPharma Investors. For...Read more
Friedman LLP is proud to sponsor and exhibit at the BioPartnering conference on May 23. In partnership with J.P. Morgan,...Read more